Z.M. NAZIPOVA¹, M.A. KUNST^1,2, А.R. AKHMADEEV², R.R. GATINA², E.S. PETROV²

¹Kazan State Medical University, 49 Butlerov Str., Kazan, Russian Federation, 420012

²Republic Clinical Hospital of the MH of RT, 138 Orenburgskiy Trakt, Kazan, Russian Federation, 420064

Nazipova Z.M. ― intern of the Department of Hospital Therapy, tel. +7-905-376-21-36, e-mail: [email protected]

Kunst M.A. ― Assistant of the Department of Hospital Therapy, tel. +7-904-760-79-20, e-mail: [email protected]

Akhmadeev A.R. ― Head of the Hematology Department, tel. +7-927-240-55-90, e-mail: [email protected]

Gatina R.R. ― hematologist, tel. +7-927-438-51-22, e-mail: [email protected]

Petrov E.S. ― pathoanatomist, tel. +7-962-550-40-52, e-mail: [email protected]

The percentage of testicular tumors makes up from 1 to 1.5% in the structure of total oncological morbidity among males and 5% of all urogenital tumors. The article presents a clinical case of testicular tumor in a patient admitted with marrow hematopoiesis depression. Anamnesis data and laboratory and instrumental tests results, particularly serum tumor markers, allowed to make a diagnosis.

Key words: marrow hematopoiesis depression, hemorrhagic syndrome, testicular tumor, Waldenstrom`s disease.

REFERENCES

1. Albers P., Albrecht W., Algaba F., Bokemeyer C., Cohn-Cedermark G., Fizazi K., Horwich A., Laguna M.P. Testicular tumors. Evropeyskaya assotsiatsiya urologov, 2010, pp. 3-10 (in Russ.).
2. Matveev V.B., Polotskiy B.E., Tryakin A.A., Tyulyandin S.A., Fedyanin M.Yu., Figurin K.M. Clinical recommendations for diagnosis and treatment of patients with germicogenic testicular tumors. Assotsiatsiya onkologov Rossii, 2014, pp. 9-18 (in Russ.).